Malwarebytes was founded in 2008 by Marcin Kleczynski and Bruce Harrison. Malwarebytes has not officially endorsed a plan to participate in an IPO.
Malwarebytes is a developer of anti-malware software. Per Forge data, Malwarebytes raised $180 million in funding over 3 rounds. Their latest funding was raised on Sep 21, 2022. Key investors include Vector Capital, Fidelity, and Highland Capital Partners.
These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Malwarebytes is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own Malwarebytes pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
Malwarebytes is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.